NASDAQ · STOCK
Steris
$228.46
52W $195.14 – $269.44
61/100
$22.26B
28.7
0.92
Is STE Bullish or Bearish?
Bullish.
Innellis AI committee rates Steris (STE) Buy with a composite score of 61/100
, based on 7 analysts with 57% agreement.
Last updated August 01, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +14.06 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -5.94 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- EPS growing 27.9% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 28.5 is moderate-to-rich — Value
- 2 consecutive earnings misses -- execution concerns — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 01, 2026
Overall Committee Score
61/100
Agreement
57%
Analysts
7
Conviction
Contested
Sector Rank
Top 16%
of 93 Healthcare peers
Value Analyst
neutral
55
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 28.5 is moderate-to-rich
Growth Analyst
neutral
58
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ EPS growing 27.9% YoY
− 2 consecutive earnings misses -- execution concerns
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
61
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2535.03)
Investment Thesis Evolution
Committee score moved marginally from 59.1 to 60.9.
- Conviction changed from moderate to contested.
- Committee agreement fell notably from 71% to 57%.
- New bearish signals: 2 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance neutral->bullish; score 58->70 (+12).
- Portfolio Manager: +2 bearish signal(s).
Comparing 2026-07-31 to 2026-08-01 (1 day apart).
Technical Analysis
RSI (14)
63.1
Neutral
MACD Histogram
1.876
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Support
$210.23
Resistance
$252.76
Bollinger %B
0.85
Inside Bands
Price vs Moving Averages
EMA 9
$224.13
Above
EMA 21
$219.01
Above
EMA 50
$216.37
Above
EMA 200
$226.69
Above
Fundamental Analysis
Valuation
73
Growth
57
Profitability
0
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio
28.7×
P/B Ratio
3.12×
PEG Ratio
1.04
Dividend Yield
0.01%
52W High
$269.44
52W Low
$195.14
Quality & Growth
ROE
10.9%
ROA
7.3%
Gross Margin
44.2%
Operating Margin
18.6%
Revenue Growth YoY
—
Debt / Equity
0.29
AI Fundamental Assessment
P/E ratio of 28.7 (moderate relative to a 15-40x range); Price-to-book of 3.1x; PEG ratio of 1.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.1%; Return on assets of 0.1%; Net margin of 0.1%; Gross margin of 0.4%; Current ratio of 2.09 (healthy short-term liquidity); Debt-to-equity of 0.29; Free cash flow margin of 0.7% (thin cash generation); Free cash flow per share is positive (9.92); Most recent quarter missed estimates by 1.6%; 2 consecutive earnings misses; EPS growth accelerating (+2.4% -> +11.9% QoQ); Analyst estimates rising over recent quarters
Get the Full STE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →